GVS
870976
Hangzhou CNCR-IT
300250
Shanghai Newtouch Software
688590
Ucap Cloud Information Technology Co.,Ltd
688228
Yangtze Optical Electronic
688143
CN Stock MarketDetailed Quotes
688163 Shanghai Serum Bio-Technology
- 17.37
- +0.28+1.64%
Market Closed Jan 24 15:00 CST
1.88BMarket Cap36.88P/E (TTM)
17.37High16.90Low8.75KlotVolume17.01Open17.09Pre Close15.01MTurnover1.97%Turnover Ratio48.52P/E (Static)108.22MShares22.9252wk High1.69P/B770.74MFloat Cap10.6652wk Low20.51Limit Up44.37MShs Float61.02Historical High13.67Limit Down2.75%Amplitude10.66Historical Low0.32Dividend TTM17.16Avg Price3.04KlotAsk1.84%Div YieldTTM100Lot Size5.39KlotBid
Shanghai Serum Bio-Technology News
Syren Biotech: Announcement on holding the results briefing for the third quarter of 2024
Syren Biotech: Announcement of Resolutions of the First Meeting of the Fourth Board of Supervisors
Syren Biotech: Investor Relations Activity Record Form (September 2024)
Independent Director Nominee\'s Statement and Commitment (Ye Yunping)
Independent Director Nominee\'s Statement and Commitment (Liu Junling)
Independent Director Nominee\'s Statement and Commitment (Fu Yishang)
Independent Director Candidate Statement and Commitment (Ye Yunping)
Independent Director Candidate Statements and Commitments (Liu Junling)
Independent Director Candidate Statement and Commitment (Fu Yishang)
Fangzheng Securities Underwriting and Sponsorship Co., Ltd. report on the 2024 semi-annual continuous supervision and follow-up report of Shanghai Sailun Biotechnology Co., Ltd.
Syren Biotech: Special Report on the Storage and Actual Use of Funds Raised for the Semi-Annual Year 2024
Syren Biotech: Semi-Annual Evaluation Report on the 2024 “Improve Quality, Increase Efficiency, and Value Rewards” Action Plan
Syren Biotech: Announcement of Resolutions of the 16th Meeting of the 3rd Board of Supervisors
Legal opinion from JinTianCheng Law Firm, Shanghai, regarding the shareholding of one of the actual controlling persons, directors, general managers, and some senior management personnel of Shanghai Cellon Biotechnology Co., Ltd.
Fangzheng Securities Underwriting and Sponsorship Co., Ltd. report on the 2023 continuous supervision and follow-up report of Shanghai Sailun Biotechnology Co., Ltd.
Shanghai Serum Bio-Technology: Announcement on attending the 2023 Biological Products Special Group Results Briefing and the 2024 First Quarter Results Briefing
Tianji International Accounting Firm (Special General Partnership) Verification Report on the Storage and Actual Use of Funds Raised by Syren Biotech
Shanghai Serum Bio-Technology: Special report on the storage and actual use of funds raised in 2023
Fangzheng Securities Underwriting and Sponsorship Co., Ltd.'s special inspection opinion on the storage and actual use of funds raised by Shanghai Sailun Biotechnology Co., Ltd. in 2023
Shanghai Serum Bio-Technology: Announcement of Resolutions of the 20th Meeting of the Third Board of Directors